Thirteen patients belonged to the previously reported series of 28 patients who received oral pyrazinamide 1500 mg (30 mg/kg for those who weighed less than 50 kg), rifampicin 600 mg (450 mg for those who weighed less than 45 kg), isoniazid 300 mg and intramuscular streptomycin 750-1000 mg daily as single doses for two months, followed by isoniazid 300 mg and rifampicin 600 mg daily for seven months.'
The other four patients received similar doses of pyrazinamide, rifampicin and isoniazid 300 mg as single daily doses for six months with streptomycin 1000 mg/day by intramuscular injection during the first two months. Lumbar punctures were periodically performed to assess response to treatment. The CSF and serum were collected three hours after a 1500 mg oral single dose of pyrazinamide at various intervals of the treatment.
Pyrazinamide was assayed spectrophotometrically by the method described by Gurumurthy et al.8 The CSF and serum levels of pyrazinamide during the first five weeks of treatment were obtained in 13 patients. In four patients the levels were measured at the 25th week of the treatment. 
